shared neoantigen-targeting cell therapy (A2 Biotherapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameshared neoantigen-targeting cell therapy (A2 Biotherapeutics)
Drug Alias Namemagic bullet peptide MHC-targeting cell therapy (A2 Biotherapeutics)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesA2 Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesA2 Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsHead and Neck NeoplasmsPancreatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A